Clinical trial
Amifostine for Head and Neck Irradiation in Lymphoma
NCT00136474 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00136474 |
|---|---|
| Title | Amifostine for Head and Neck Irradiation in Lymphoma |
| Official title | A Randomized Phase II Trial of Amifostine for Head and Neck Irradiation in Lymphoma |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Beth Israel Deaconess Medical Center MedImmune LLC Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Hodgkin's Disease, Non-Hodgkin's Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | Amifostine, Radiation Therapy |
| Enrollment | 75 |
| Start date | May 1, 2003 |
| Primary completion | May 1, 2005 |
| Completion | Mar 1, 2009 |
| First posted | Aug 29, 2005 |
| Last update posted | Nov 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: